wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38544841-056CE53C-1F6D-4FF3-94DA-DC0C1A633351
Q38544841-056CE53C-1F6D-4FF3-94DA-DC0C1A633351
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38544841-056CE53C-1F6D-4FF3-94DA-DC0C1A633351
Sorafenib: 10 years after the first pivotal trial.
P2860
Q38544841-056CE53C-1F6D-4FF3-94DA-DC0C1A633351
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38544841-056CE53C-1F6D-4FF3-94DA-DC0C1A633351
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
17dcdb329a831799a7195fe7c1641792bd7c488a
P2860
Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours.